Emerging Data in Cancer Supportive Care

Slides:



Advertisements
Similar presentations
Medical Oncology Division, Terni
Advertisements

Pubmed.gov. PubMed What is PubMed? Why should I use PubMed? What is in PubMed? What is the best way to search PubMed for HIV/AIDS information?
Chemotherapy Induced Nausea and Vomiting
欢 迎 光 临欢 迎 光 临. NCCN Clinical Practice Guidelines in Oncology™ Melanoma Lili Yun nan biotherapy center
CINVForum Web-symposium dedicated to chemotherapy induced nausea and vomiting in lung cancer patients Survey on CINV – Results Base: 168 registered physicians.
This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the US, and data that were.
The Nurse View.
Introduction. TREATMENT BASED ON TUMOR SIDEDNESS IN mCRC: THE EVIDENCE AND PRACTICAL APPLICATION.
Program Goals. Out of the Periphery and Into Comprehensive Care: Managing Diabetic Peripheral Neuropathy.
Updated CINV Guidelines New Evidence for Change and Practical Issues
Antineoplastic Medications
RISK RECOGNITION IN HEALTHCARE SETTINGS
Monitoring and Management of Adult Relapsed/Refractory Acute Promyelocytic Leukemia.
NOACs for Cancer-Associated Thrombosis:
The Current Status of Neoadjuvant Therapy in HER2-Positive Breast Cancer.
Perspectives on Triple-Negative Breast Cancer
Cancer Cachexia in GI Malignancies
Improving the Diagnosis and Treatment of Seizures in Long-term Care
The Changing Therapeutic Landscape of CINV
The Oncology Medical Home
Appropriate Stroke Prevention Strategies in Atrial Fibrillation
Program Goals. Program Goals Introduction Program Outline.
Activity Goals. Perspectives on PARP Inhibitors in Ovarian Cancer Has the Time Come for Individualized Care?
The Nurse View: Updates in the Management of Metastatic Colorectal Cancer.
The Cancer Pain Journey: Optimizing Identification and Management
What Do Primary Care Physicians Need to Know About Insulin/GLP-1 RA Fixed-Ratio Combinations?
A Closer Look at Pemphigus Vulgaris: Clinical Challenges and Emerging Treatments.
Navigating the Data and Evolving Our Approach
Program Goals. The Role of Chemotherapy in Improving Quality of Life in Advanced NSCLC.
IL-17 Inhibitors in the Management of Psoriatic Disease
Counseling Patients About Germline BRCA Mutations
Managing CINV and Cachexia
What Does the Primary Care Physician Need to Know About Chronic Hepatitis C?
Best Practices in Metastatic Colorectal Cancer
Adjuvant Dose-Dense Chemotherapy in Breast Cancer: Standard of Care in High-Risk Patients Breast Care 2016;11: DOI: / Fig. 1. Strategies.
The Nurse View: Top Ten Things to Know About Immune-Mediated Adverse Events.
Individualizing Factor Replacement Therapy for Patients With Hemophilia.
Rheumatoid Arthritis 2015 Guidelines What's New? What's Different?
EHL Technologies in Hemophilia Care
Issues in the Management of Hemophilia: A Best Practice Series
VTE in Cancer.
Mutational Testing to Select Novel Targeted Therapies in AML
Optimizing Frontline Care for Older Patients With Multiple Myeloma
Improving Therapeutic Management of Huntington's Disease in Long-Term Care.
Updates on the Management of CINV From the 2014 June Congresses
Patient-Centered Management in Pancreatic Cancer
What Does It Take to Be a Long-Acting Replacement Therapy in Hemophilia A?
Novel Insulin/GLP-1 Combinations: Of Interest to the Primary Care Physician?
Cancer-Associated Thrombosis
Treatment of Locally Advanced Pancreatic Cancer
Updates on the Prevention and Management of CINV
Patient-Centered Management in Advanced Non-Small Cell Lung Cancer
Optimizing Joint Health in Hemophilia
Treating Obesity as a Disease: What Are the Underlying Causes?
Preparing for Checkpoint Inhibitors in Breast Cancer
Factor Xa Inhibitors in Coronary Artery Disease
Improving Adherence to Antiplatelet Therapy After an ACS Event
Assessing the Burden of Hyperkalemia
Figure 1 A large number of genes are potentially associated with CIPN
Quality Improvement and Molecular Profiling in Advanced Non-Small Cell Lung Cancer.
Renal Function and Myeloma Therapeutics
Optimizing Outcomes for Patients With Systemic Lupus Erythematosus: Key Considerations.
Would Patients With Hemophilia B Benefit From Switching to Extended Half-Life Factor Products? 
What Does BRCA Have to Do With It? PARP Inhibitors in Ovarian Cancer
Clinical Pearls in the Management of Patients With Advanced Non-Small Cell Lung Cancer.
Maximizing Disease-Free Survival in Early-Stage HER2-Positive Breast Cancer.
MSI.
Combining Immunotherapy and Chemotherapy in NSCLC
Treatment Initiation and Selection in Newly Diagnosed CLL
Fresh perspectives ON BASAL Insulins in diabetes care
Presentation transcript:

Emerging Data in Cancer Supportive Care

Program Overview

Key Articles on Cancer Supportive Care

ESMO Position Paper

CINV

MASCC/ESMO Guidelines

MASCC/ESMO Guidelines (cont)

Cisplatin Dose and Nausea Control

Cisplatin Dose and Nausea Control (cont)

Dexamethasone-Sparing Regimens

Dexamethasone-Sparing Regimens (cont)

Prediction Tool for Patients at High Risk for CINV

Prediction Tool for Patients at High Risk for CINV (cont)

Cachexia and Malnutrition

Management of Cachexia/Anorexia: Anamorelin

Management of Cachexia/Anorexia: Anamorelin (cont)

Management of Cachexia/Anorexia: Other Agents

Management of Cachexia/Anorexia: Other Agents (cont)

Family-Centered Nutritional Intervention

Family-Centered Nutritional Intervention (cont)

Chemotherapy-Induced Diarrhea

Management of Chemotherapy-Induced Diarrhea: The Effect of Exercise

Management of Chemotherapy-Induced Diarrhea: Gut Microbes and Elsiglutide

Chemotherapy-Induced Peripheral Neuropathy

Chemotherapy-Induced Peripheral Neuropathy (cont)

Chemotherapy-Induced Peripheral Neuropathy: Unmet Needs

Summary

Abbreviations

Abbreviations (cont)